BMY vs MYSEW · P/E 17, rev $24.46B vs rev $436
Bristol-Myers Squibb Company (BMY) versus Myseum, Inc. (MYSEW) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Myseum, Inc. (MYSEW) common stock listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MYSEW revenue for 2024-12-31 was $436. Net income was -$5.0M. Revenue was down 35.1% from 2023-12-31 to 2024-12-31. MYSEW currently screens at market cap $0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MYSEW currently screens at market cap $0.
Not investment advice. Open the BMY and MYSEW stock pages for the full models.
Not investment advice.